RESEARCH TRIANGLE PARK, N.C., Oct. 11 /PRNewswire-FirstCall/ -- Talecris Biotherapeutics Holdings Corp. (Nasdaq: TLCR) will issue its third quarter 2010 earnings release before the market opens on October 28, 2010. Due to the pending merger with Grifols, S.A., Talecris will not be hosting a conference call to discuss its third quarter results.
About Talecris Biotherapeutics: Inspiration. Dedication. Innovation.
Talecris Biotherapeutics is a global biotherapeutic and biotechnology company that discovers, develops and produces critical care treatments for people with life-threatening disorders in a variety of therapeutic areas including immunology, pulmonology, neurology and hemostasis. For more information, please visit: www.talecris.com.